Sales Support:
sales@worldwidemarketreports.com
U.S. :+1 415 871 0703
U.K. :+44-203-289-4040
AUS. : +61-2-4786-0457
INDIA :+91-848-285-0837
Menu Icon Close Icon
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global Antiretroviral Drugs Market: Analysis By Drug Type (Multi-Class Drugs Combination Drugs, NRTI, NNRTI, Protease Inhibitors), By Region, By Country, Drug Forecast (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India, South Africa)

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of antiretroviral market. The report analyses the Antiretroviral Market By Drug Type (Multi-Class Drugs Combination Drugs, NRTI, NNRTI, Protease Inhibitors, and Others). The report analyses the antiretroviral market, By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India, and South Africa) for the historical period of 2013-2017 and the forecast period of 2018-2023. This report also includes drug sales forecast for some antiretroviral drugs.

According to Azoth Analytics research report "Global Antiretroviral Market: Analysis By Drug Type (Multi-Class Drugs Combination Drugs, NRTI, NNRTI, Protease Inhibitors, and Others), By Region (North America, Europe, Asia Pacific, ROW), By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India, and South Africa), Drug Forecast (2019 Edition): Forecast to 2023", the antiretroviral market is projected to display a robust growth represented by a CAGR of 4.70% during 2018 - 2023.
Over the recent years, Antiretroviral drugs market has been witnessing growth on account of several driving factors including growing prevalence of HIV AIDS, growing antiretroviral treatment coverage rate, and increase in availability of novel drugs with better efficacy. Moreover, factors such as growing medical spending, favorable steps by government of various countries, decreased cost of treatment, improved diagnosis rate, and rise in the favorable programs to provide diagnosis and treatment facilities to the unmet patient population has been driving the market growth of antiretroviral drugs. In addition, increasing uptake of INSTI based regimens, increasing awareness regarding HIV care and treatment procedures, new drug launches, and improved R&D pipeline are anticipated to fuel the market growth in forecasted period. However, growing portfolio of generic antiretroviral drugs is expected impact the overall market growth.

In this research report, the market is segmented on the basis of drug type. By drug type, the multi-class drug combinations are predicted to hold their dominant position in the market, especially Gilead Sciences product Biktarvy and ViiV Healthcare product Triumeq are expected to give more traction to the market. Amongst the regions, North America accounts for the largest regional share in the global antiretroviral market in 2017. The largest share of North America is attributed to high ART coverage rate and more emphasis towards prescribed branded drugs.

The report titled "Global Antiretroviral Market: Analysis By Drug Type (Multi-Class Drugs Combination Drugs, NRTI, NNRTI, Protease Inhibitors, and Others), By Region (North America, Europe, Asia Pacific, ROW), By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India, and South Africa), Drug Forecast (2019 Edition): Forecast to 2023" has covered and analysed the potential of antiretroviral drugs market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the antiretroviral market. Additionally, the report also highlights market entry strategies for various companies across the globe along with drug sales forecast analysis.

Scope of the Report

Global Antiretroviral Drugs Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Antiretroviral Drugs Market- Size, Growth, Forecast
• Analysis By Drug Type - Multi-Class Drugs Combination Drugs, NRTI, NNRTI, Protease Inhibitors, and Others.
• Drug Sales Forecast:
o Multi-Class Drugs Combination: Juluca®, Triumeq®, Genvoya®, Odefsey®, Stribild®, Biktarvy®.
o Nucleoside Reverse Transcriptase Inhibitors: Epzicom®/ Kivexa®.
o Non-Nucleoside Reverse Transcriptase Inhibitors: Edurant®.
o Protease Inhibitors: PREZISTA ® /PREZCOBIX® /REZOLSTA ®.
o Integrase Strand Transfer Inhibitors: Tivicay®, Isentress/Isentress HD®.
o CCR5 Inhibitor: Selzentry®/ Celsentri®.

Regional Antiretroviral Drugs Market - North America, Europe, Asia Pacific, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Antiretroviral Drugs Market- Size, Growth, Forecast
• Analysis By Drug Type - Multi-Class Drugs Combination Drugs, NRTI, NNRTI, Protease Inhibitors, and Others.

Country Analysis - U.S., Canada, Germany, U.K, France, Italy, China, Japan, India, and South Africa (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Antiretroviral Drugs Market- Size, Growth, Forecast
• Analysis By Drug Type - Multi-Class Drugs Combination Drugs, NRTI, NNRTI, Protease Inhibitors, and Others.

Other Report Highlights
• Product Sales Forecast.
• Market Dynamics - Drivers and Restraints.
• Market Trends.
• Porter Five Forces Analysis.
• SWOT Analysis.
• Company Analysis - Gilead Sciences Inc., ViiV Healthcare, Bristol-Myers Squibb, AbbVie Inc., Boehringer Ingelheim, Johnson & Johnson, Merck & Co., Cipla, Mylan.

Customization of the Report
The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research. 

Table of Contents

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Antiretroviral Drugs Products Outlook

5. Global Antiretroviral Drugs Market: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)

6. Global Antiretroviral Drugs Market: Segment Analysis
6.1 Global Antiretroviral Drugs Market Size, By Drug Type: Breakdown (%)
6.1.1 Global Antiretroviral Drugs Market Size, By Drug Type, 2017 (%)
6.1.2 Global Antiretroviral Drugs Market Size, By Drug Type, 2023 (%)
6.2 Global Multi-Class Drugs Combination Market Size, By Value (2013-2023)
6.3 Global NRTI Market Size, By Value (2013-2023)
6.4 Global NNRTI Market Size, By Value (2013-2023)
6.5 Global Protease Inhibitors Market Size, By Value (2013-2023)
6.6 Global Other Antiretroviral Drugs Market Size, By Value (2013-2023)
6.6 Global Antiretroviral Drugs: Market Attractiveness, By Drug Type
6.7 Global Market: Drugs Forecast (Multi-Class Drugs Combination, NRTI, NNRTI, Protease Inhibitors, CCR5) 

7. Global Antiretroviral Drugs Market: Regional Analysis
7.1 Global Antiretroviral Drugs Market Size, By Region : Breakdown (%)
7.1.1 Global Antiretroviral Drugs Market Size, By Region, 2017 (%)
7.1.2 Global Antiretroviral Drugs Market Size, By Region, 2023 (%)

8. North America Antiretroviral Drugs Market: Growth and Forecast
8.1 North America Antiretroviral Drugs Market: Segmental Analysis
8.2 North America Antiretroviral Drugs Market Size, By Drug Type: Breakdown (%)
8.2.1 North America Antiretroviral Drugs Market Size, By Drug Type, 2017 (%)
8.2.2 North America Antiretroviral Drugs Market Size, By Drug Type, 2023 (%)
8.3 North America Multi-Class Drugs Combination Market  Size, By Value (2013-2023)
8.4 North America  NRTI Market Size, By Value (2013-2023)
8.5 North America NNRTI Market Size, By Value (2013-2023)
8.6 North America Protease Inhibitors Market Size, By Value (2013-2023)
8.7 North America Other Antiretroviral Drugs Market Size, By Value (2013-2023)

8.9 North America Antiretroviral Drugs Market: Country Analysis (U.S and Canada)
8.9.1 U.S Antiretroviral Drugs Market, By Value (2013-2023)
8.9.2 U.S Antiretroviral Drugs Market, By Drug Type, By Value (2013-2023)

8.9.3 Canada Antiretroviral Drugs Market, By Value (2013-2023)
8.9.4 Canada Antiretroviral Drugs Market, By Drug Type, By Value (2013-2023)

9. Europe Antiretroviral Drugs Market: Growth and Forecast
9.1 Europe Antiretroviral Drugs Market: Segmental Analysis
9.2 Europe Antiretroviral Drugs Market Size, By Drug Type: Breakdown (%)
9.1.2 Europe Antiretroviral Drugs Market Size, By Drug Type, 2017 (%)
9.1.3 Europe Antiretroviral Drugs Market Size, By Drug Type, 2023 (%)
9.3 Europe Multi-Class Drugs Combination Market Size, By Value (2013-2023)
9.4 Europe NRTI Market Size, By Value (2013-2023)
9.5 Europe NNRTI Market Size, By Value (2013-2023)
9.6 Europe Protease Inhibitors Market Size, By Value (2013-2023)
9.7 Europe Other Antiretroviral Drugs Market Size, By Value (2013-2023)

9.8 Europe Antiretroviral Drugs Market: Country Analysis (Germany, France, U.K, Italy)

9.8.1 Germany Antiretroviral Drugs Market, By Value (2013-2023)
9.8.2 Germany Antiretroviral Drugs Market, By Drug Type, By Value (2013-2023)

9.8.4 France Antiretroviral Drugs Market, By Value (2013-2023)
9.8.5 France Antiretroviral Drugs Market, By Drug Type, By Value (2013-2023)

9.8.6 UK Antiretroviral Drugs Market, By Value (2013-2023)
9.8.7 UK Antiretroviral Drugs Market, By Drug Type, By Value (2013-2023)

9.8.8 Italy Antiretroviral Drugs Market, By Value (2013-2023)
9.8.9 Italy Antiretroviral Drugs Market, By Drug Type, By Value (2013-2023)

10. APAC Antiretroviral Drugs Market: Growth and Forecast

10.1 APAC Antiretroviral Drugs Market: Segmental Analysis
10.2 APAC Antiretroviral Drugs Market Size, By Drug Type: Breakdown (%)
10.2.1 APAC Antiretroviral Drugs Market Size, By Drug Type, 2017 (%)
10.2.2 APAC Antiretroviral Drugs Market Size, By Drug Type, 2023 (%)
10.3 APAC Multi-Class Drugs Combination Market  Size, By Value (2013-2023)
10.4 APAC NRTI Market Size, By Value (2013-2023)
10.5 APAC NNRTI Market Size, By Value (2013-2023)
10.6 APAC Protease Inhibitors Market Size, By Value (2013-2023)
10.7 APAC Other Antiretroviral Drugs Market Size, By Value (2013-2023)

10.8 APAC Antiretroviral Drugs Market: Country Analysis (China, Japan, and India) 
10.8.1 China Antiretroviral Drugs Market, By Value (2013-2023) 
10.8.2 China Antiretroviral Drugs Market, By Drug Type, By Value (2013-2023) 

10.8.3 Japan Antiretroviral Drugs Market, By Value (2013-2023) 
10.8.4 Japan Antiretroviral Drugs Market, By Drug Type, By Value (2013-2023) 

10.8.5 India Antiretroviral Drugs Market, By Value (2013-2023) 
10.8.6 India Antiretroviral Drugs Market, By Drug Type, By Value (2013-2023) 

11. ROW Antiretroviral Drugs Market: Growth and Forecast
11.1 ROW Antiretroviral Drugs Market: Segment Analysis
11.2 ROW Antiretroviral Drugs Market Size, By Drug Type: Breakdown (%)
11.1.1 ROW Antiretroviral Drugs Market Size, By Drug Type, 2017 (%)
11.1.2 ROW Antiretroviral Drugs Market Size, By Drug Type, 2023 (%)
11.3 ROW Multi-Class Drugs Combination Market  Size, By Value (2013-2023) 
11.4 ROW NRTI Market Size, By Value (2013-2023) 
11.5 ROW NNRTI Market Size, By Value (2013-2023) 
11.6 ROW Protease Inhibitors Market Size, By Value (2013-2023) 
11.7 ROW Other Antiretroviral Drugs Market Size, By Value (2013-2023) 

11.8 ROW Antiretroviral Drugs Market: Country Analysis (China, Japan, and India)
11.8.1 South Africa Antiretroviral Drugs Market, By Value (2013-2023)
11.8.2 South Africa Antiretroviral Drugs Market, By Drug Type, By Value (2013-2023)

12. Global Antiretroviral Drugs Market: Market Dynamics 
12.1 Global Antiretroviral Drugs Market: Drivers 
12.2 Global Antiretroviral Drugs Market: Restrains 
12.3 Global Antiretroviral Drugs Market: Trends 
12.4 Global Antiretroviral Drugs Market: Product Benchmarking 

13. Porter Five Force Analysis

14. SWOT Analysis

15. Company Profiles
15.1 Gilead Sciences
15.2 ViiV Healthcare
15.3 Bristol-Myer Squibb
15.4 AbbVie Inc.
15.5 Boehringer-Ingelheim
15.6 Johnson and Johnson
15.7 Merck & Co.
15.8 CIPLA
17.9 Merck & Co,
Healthcare and Pharmaceuticals

mRNA Vaccine Drugs Development Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)

  Price : US$ 3,500   Date : Oct 2024
  Category : Healthcare and Pharmaceuticals   Pages : 132
Medical Devices

Asia Pacific Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 2,955   Date : Jul 2024
  Category : Medical Devices   Pages : 143
Medical Devices

Europe Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 2,955   Date : Jul 2024
  Category : Medical Devices   Pages : 140
Medical Devices

North America Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 2,955   Date : Jul 2024
  Category : Medical Devices   Pages : 135
Medical Devices

Global Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3,985   Date : Jul 2024
  Category : Medical Devices   Pages : 162

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.

Related Reports

MRNA Vaccine Drugs Development Services Market Size And Share Analysis - Growth Trends And Fo...
View More
Asia Pacific Photodynamic Therapy Market Size, Share, Trends & Analysis By Product Type (Phot...
View More
Europe Photodynamic Therapy Market Size, Share, Trends & Analysis By Product Type (Photodynam...
View More
North America Photodynamic Therapy Market Size, Share, Trends & Analysis By Product Type (Pho...
View More
Global Photodynamic Therapy Market Size, Share, Trends & Analysis By Product Type (Photodynam...
View More

Trusted Clients
A-T- Kearney.png
AbbVie.png
Agrinos.png
AIF-Metrics.png
Akzo-Nobel.jpg
Alfi-GMBH.png
Allergan.png
Almasra-Scientific-Bureau.jpg
ALPMA.jpg
Americana-Foods.png
ANP.png
Aptar-Group-Germany.jpg
asahi-kasei.png
ATC.png
atlas-servair.jpg
ATOS.png
Avalon.png
biofishency.png
biomx.png
borealisgroup.png
Cape-Peninsula.png
CBRE.png
Cennerv-Pharma.jpg
Clearponds.png
Compass-Group.png
Cortag-Industria.png
Covis-Pharma.jpg
DAIMLER-AG.jpg
Edipresse-Media.jpg
Epson.png
Evonik-Industries-AG.png
ExcelSource.png
Fingo.png
Firstkind.png
FLM-Foodingredients.png
Freudenberg.png
Fueltrax.jpg
Fugro-International.png
Fuji-Films.png
Funky-Sound-Studio.png
GALTWAY.png
Gartner.png
GBSC.png
Global-Information.jpg
Hanwha-Total-Petrochemical.png
Hebrew.png
Horiba-Mira.png
Hunter-and-Co-Investments.png
Hyosung.png
Hyssopus-Organics.jpg
IBSA.png
Ideagen.png
IMS.png
InSinkErator.png
Intas-Pharma.png
IntelMed-Sarl.png
Interdiligence-Consulting.png
Israel-Shopyards.png
Johnsons-Controls.png
kakaxi.jpg
KORDSA.png
kotra.png
KPMG.png
lantmannen.png
LEK.png
LG.jpg
Makuri-Technology.jpg
Mallinckrodt.png
Mappo.png
Maprimed.jpg
mcns.jpg
MED-EL.png
Mehr-Azin-Pouya-Sahand.png
Molkerei-Ammerland-eG.png
Monty-Holding.jpg
mpmaterials.png
Mundipharma.png
Nasco.png
Nitto.png
Nouryon.png
NOXTAK.png
Oskars.png
Paidotribo.png
Parnell-Pharmaceuticals.png
Podravka.png
ppg.png
Privi.png
Publicis Groupe.png
Qvetech.jpg
R3P.jpg
Samsung.png
Sapient.png
SEW-EURODRIVE.png
Shivananda.jpg
Silver-Clouds.png
SMIT.jpg
SOLVIAS.png
Spectrum.png
SR-Instruments-Oy.png
Star-Seed.png
Stryker -ENT.png
Synjenta.png
Terumo-Corp.png
TherOzone.png
Toshiba.png
TT-Electronics.png
umbc.edu.png
Vard.jpg
Vital-Xense.png
Walraven.png
Wlgore.png
Woodmac.png
WWF-UK.png
ZENOAQ.png
Zuellig-Pharma.png
Contact us

sales@worldwidemarketreports.com

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

phoneiconU.S. : +1 415 871 0703

phoneiconU.K. : +44-203-289-4040

phoneiconAUS. :+61-2-4786-0457

phoneiconIndia :+91-848-285-0837

Menu
Quick Links
Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved